<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="112517">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01638481</url>
  </required_header>
  <id_info>
    <org_study_id>58802-LS</org_study_id>
    <nct_id>NCT01638481</nct_id>
  </id_info>
  <brief_title>Chronology of Occult and Gross Coagulopathy in Burn Patients</brief_title>
  <official_title>Determining the Chronology of Occult and Gross Coagulopathy in Thermally Injured Patients: A Systems Biology Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medstar Health Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>United States Department of Defense</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Medstar Health Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to identify the inflammatory and coagulation pathways and
      mechanisms that are activated immediately following burn injury, and how they affect
      outcomes in terms of organ failure and death. This study also addresses the limitation of
      current tests (PT, PTT, and platelet counts) employed to identify coagulation disturbances
      in severely injured patients both in a comprehensive and rapid manner.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">85</enrollment>
  <condition>Thermal Burns</condition>
  <arm_group>
    <arm_group_label>Group #1 - Burns affecting less than 10% BSA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group #2 - Burns affecting 10%-30% TBSA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group #3 - Burns affecting 31%-50% TBSA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group #4 - Burns affecting 51%-70% TBSA</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Group #5 - Burns affecting &gt;70% TBSA</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Burn injury patients will be enrolled in the study upon arrival at Trauma Center.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients, male or female, &gt; or = 18 years of age, who arrive at Burn/Trauma Center
             with anticipated admission to The Burn Center within 4 hours of injury, with a
             thermal burn injury due to flash, flame, contact with hot object or liquid.

        Exclusion Criteria:

          -  Patients suffering concomitant trauma that are in hemorrhagic shock. Patients with a
             preexisting history of coagulopathy, or currently taking anti-coagulants. Children
             and pregnant women. Patients with chemical or electrical injury. Patients who do not
             fluently speak either English or Spanish.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeffrey Shupp, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington Hospital Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Melissa McLawhorn</last_name>
    <phone>202-877-6181</phone>
    <email>melissa.m.mclawhorn@medstar.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jeffrey Shupp, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 13, 2016</lastchanged_date>
  <firstreceived_date>July 9, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
